Which would you choose – $500 or the medication that effectively manages your condition? It’s a tough choice, but one that patients across the country now face.
For too long, patients have been getting bumped off their physician-prescribed medication in favor of a different medication – one preferred by their insurance company.
Insurers continue to manipulate their formularies to boost profits, new data from Maine suggest.
A new report out of Maine paints a daunting picture of non-medical switching – and how it affects patients.
The story has become a familiar one. A patient with a chronic condition works with his or her doctor to find the right treatment. The condition is stabilized, manageable.
Health plans’ attempts to cut costs can wreak havoc on patients’ lives, new research makes clear.
Voters want limits on non-medical switching – and they’re looking to legislators for policy solutions.
What do Maine and Illinois have in common? Legislators in both states are heeding patients’ concerns about non-medical switching this year.
In a week already marked by fireworks and parades, patients in Maine have one more thing to celebrate. A new state law draws clear lines about non-medical switching, protecting chronic disease patients who want to stick with the doctor-prescribed medicine that keeps them stable.
Health benefits designs in both private and public health insurance programs include mechanisms to control the costs of care, resulting in many health care choices being made with a focus on financial concerns that could outweigh clinical factors. This can particularly be true for interventions involving prescription drugs and biologics. In some cases, choice of […]